Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: Arthritis Care Res (Hoboken). 2019 Jan;71(1):126–133. doi: 10.1002/acr.23576

Table 5.

Multivariate Relationships for Obesity and Covariates with Patient Reported Outcomes

SLAQ CES-D SF-36 Pain SF-36 Vitality
β (P) β (P) β (P) β (P)
Obese by FMI ≥ 13 kg/m2 3.33 (0.01) 6.67 (0.004) −5.55 (0.004) −5.66 (0.01)
Age 0.11 (0.06) 0.02 (0.82) −0.16 (0.05) −0.20 (0.03)
Race 0.82 (0.52) 5.96 (0.01) −1.62 (0.38) −4.77 (0.02)
Low education1 −0.64 (0.72) −2.57 (0.41) −0.45 (0.86) −1.00 (0.73)
Poverty level income2 3.01 (0.10) 8.67 (0.01) −3.06 (0.24) −6.39 (0.03)
Smoking, current 3.91 (0.14) 0.80 (0.86) −2.95 (0.44) −0.24 (0.96)
Disease Duration −0.19 (0.01) −0.01 (0.92) 0.08 (0.45) 0.18 (0.15)
BILD Score 0.69 (0.02) 0.51 (0.31) −1.23 (0.004) −0.90 (0.06)
Prednisone > 7.5 mg/day 3.33 (0.03) 2.65 (0.31) −5.73 (0.01) −2.38 (0.33)
Model F value (df) 3.72 2.98 3.98 3.28
Model R2 0.21 0.18 0.23 0.19
Model Adjusted R2 0.16 0.12 0.17 0.13

SLAQ, Systemic Lupus Activity Questionnaire; CES-D, Center for Epidemiologic Studies Depression Scale; SF-36 Pain, Short Form 36 Health Survey Pain Subscale (higher scores indicate less pain); SF-36 Vitality, Short Form 36 Vitality Subscale (higher scores indicate less fatigue); FMI, fat mass index; BILD, Brief Index of Lupus Damage; DMARD, Disease-modifying antirheumatic drugs.

1

No education beyond high school.

2

Household income ≤ 125% of the federal poverty level.

HHS Vulnerability Disclosure